Total Payments
$76,189
2024 Payments
$24,716
Companies
24
Transactions
256
Medicare Patients
16,282
Medicare Billing
$8.9M
Payment Breakdown by Category
Other$61,553 (80.8%)
Travel$7,608 (10.0%)
Food & Beverage$6,616 (8.7%)
Consulting$400.00 (0.5%)
Education$12.70 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,760 | 23 | 77.1% |
| Travel and Lodging | $7,608 | 22 | 10.0% |
| Food and Beverage | $6,616 | 198 | 8.7% |
| Acquisitions | $1,663 | 1 | 2.2% |
| Current or prospective ownership or investment interest | $1,130 | 5 | 1.5% |
| Consulting Fee | $400.00 | 1 | 0.5% |
| Education | $12.70 | 1 | 0.0% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
General
$76,189
251 transactions
Ownership
$0
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $32,201 | 53 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $27,018 | 53 | $0 (2024) |
| ABBVIE INC. | $10,319 | 19 | $0 (2024) |
| US Retina LLC | $2,792 | 11 | $0 (2023) |
| Alcon Vision LLC | $968.95 | 9 | $0 (2023) |
| Genentech USA, Inc. | $802.94 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $410.07 | 19 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $229.36 | 9 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $224.68 | 7 | $0 (2024) |
| Coherus Biosciences Inc. | $219.73 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,716 | 38 | Regeneron Healthcare Solutions, Inc. ($24,180) |
| 2023 | $6,904 | 32 | AbbVie Inc. ($2,485) |
| 2022 | $14,445 | 51 | ABBVIE INC. ($7,704) |
| 2021 | $6,635 | 38 | Allergan, Inc. ($5,608) |
| 2020 | $4,410 | 25 | Allergan, Inc. ($3,839) |
| 2019 | $1,054 | 18 | Allergan Inc. ($442.82) |
| 2018 | $17,475 | 37 | Allergan Inc. ($17,158) |
| 2017 | $549.77 | 17 | Allergan Inc. ($253.12) |
All Payment Transactions
256 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,780.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: EYE CARE | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/07/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,464.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $121.54 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $899.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $101.51 | General |
| Category: Ophthalmology | ||||||
| 10/08/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: EYE CARE | ||||||
| 08/20/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Ophthalmology | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,116.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/20/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: OPTOMETRY | ||||||
| 06/04/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: EYE CARE | ||||||
| 05/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $114.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Ophthalmology | ||||||
| 05/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 4,481 | 17,671 | $6.9M | $2.4M |
| 2022 | 18 | 4,211 | 12,101 | $5.5M | $2.3M |
| 2021 | 18 | 3,850 | 12,278 | $5.4M | $2.3M |
| 2020 | 19 | 3,740 | 10,501 | $4.4M | $1.9M |
Total Patients
16,282
Total Services
52,551
Medicare Billing
$8.9M
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 215 | 2,134 | $3.5M | $1.4M | 40.6% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 23 | 5,820 | $449,462 | $161,252 | 35.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 40 | 886 | $553,586 | $158,195 | 28.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 335 | 1,500 | $639,540 | $136,850 | 21.4% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 25 | 393 | $386,770 | $85,232 | 22.0% |
| 92134 | Imaging of retina | Office | 2023 | 974 | 2,517 | $196,790 | $73,735 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 366 | 708 | $105,663 | $47,981 | 45.4% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 13 | 308 | $115,381 | $46,997 | 40.7% |
| J3490 | Unclassified drugs | Office | 2023 | 15 | 25 | $142,600 | $45,599 | 32.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 506 | 515 | $114,932 | $43,429 | 37.8% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 13 | 255 | $165,555 | $30,692 | 18.5% |
| 92250 | Photography of the retina | Office | 2023 | 874 | 1,115 | $140,490 | $29,319 | 20.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 351 | 431 | $77,963 | $25,740 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 180 | 180 | $59,620 | $21,228 | 35.6% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 20 | 20 | $72,400 | $18,017 | 24.9% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 388 | 620 | $49,600 | $7,177 | 14.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 32 | 83 | $25,800 | $5,224 | 20.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $10,316 | $4,511 | 43.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 18 | 57 | $17,300 | $2,864 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $5,720 | $2,563 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 20 | $3,640 | $1,699 | 46.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 29 | 39 | $8,979 | $1,373 | 15.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 193 | 2,022 | $3.0M | $1.4M | 47.4% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 65 | 1,754 | $1.1M | $383,947 | 36.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 307 | 1,486 | $485,400 | $134,377 | 27.7% |
About Dr. Benjamin Thomas, MD
Dr. Benjamin Thomas, MD is a Ophthalmology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1427290360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Thomas, MD has received a total of $76,189 in payments from pharmaceutical and medical device companies, with $24,716 received in 2024. These payments were reported across 256 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($58,760).
As a Medicare-enrolled provider, Thomas has provided services to 16,282 Medicare beneficiaries, totaling 52,551 services with total Medicare billing of $8.9M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Retina Specialist
- Location Jacksonville, FL
- Active Since 03/24/2009
- Last Updated 04/20/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1427290360
Products in Payments
- OZURDEX (Drug) $37,260
- EYLEA HD (Biological) $26,233
- NGENUITY (Device) $690.68
- EYLEA (Biological) $573.96
- Lucentis (Biological) $514.92
- BEOVU (Drug) $410.07
- Cimerli (Biological) $239.51
- XIPERE (Drug) $224.68
- EYLEA AFLIBERCEPT INJECTION (Biological) $210.11
- Vabysmo (Drug) $152.24
- Luxor (Device) $140.40
- Constellation (Device) $137.87
- Syfovre (Drug) $137.12
- CyPass (Device) $128.44
- VABYSMO (Drug) $118.51
- ACTHAR (Biological) $97.03
- Tecnis 1-piece IOL (Device) $92.20
- Iluvien (Drug) $79.83
- YUTIQ (Drug) $70.31
- BYOOVIZ (Biological) $56.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Jacksonville
Syril Dorairaj, Md, MD
Ophthalmology — Payments: $542,154
Ophthalmology $542,154
Jeffrey Levenson, M.d, M.D
Ophthalmology — Payments: $435,025
Ophthalmology $435,025
Dr. Frank Bowden, M.d, M.D
Ophthalmology — Payments: $213,959
Ophthalmology $213,959
David Kostick, Md, MD
Ophthalmology — Payments: $96,443
Ophthalmology $96,443
Ron Adelman, Md, MD
Ophthalmology — Payments: $62,231
Ophthalmology $62,231
Sandeep Grover, Md, MD
Ophthalmology — Payments: $59,037
Ophthalmology $59,037